With Donanemab on the Cusp of Approval, Proper Alzheimer’s Diagnosis Is Urgent

Accurately diagnosing Alzheimer’s disease pathologies is becoming increasingly important, but the U.S. is facing imaging resource constraints.

Scroll to Top